Showing 521-530 of 10227 results for "".
Updates on AD Therapeutics
https://practicaldermatology.com/topics/atopic-dermatitis/updates-on-ad-therapeutics/19760/It's a "super-exciting" time in the world of atopic dermatitis because of a number of new developments happening very rapidly, shares Peter Lio, MD. Recent approvals and additional indications for treatments like dupilumab and crisaborole in pediatric populations have been welcome additions. And theShow and tell – infographic marketing tips for dermatologists
https://practicaldermatology.com/topics/practice-management/show-and-tell-infographic-marketing-tips-for-dermatologists/19693/Do you struggle to communicate research studies, statistics, aftercare instructions, and other complex ideas to your patients? This Ekwa Marketing video shows you how to simplify data and give it visual appeal with infographics.Don't Shoot the Messenger
https://practicaldermatology.com/topics/practice-management/dont-shoot-the-messenger/20791/Act now to avoid a seven percent MIPS penalty in 2021.Bespoke for Bros: A Different Approach for Male Patients
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/bespoke-for-bros-a-different-approach-for-male-patients-/19561/Physical features aside, there may be important differences in how male patients think about and approach cosmetic concerns. According to Heidi Waldorf, MD, while women tend to seek a youthful appearance, men often want to appear as though they have not aged—and stopping the aging clock requires a fDupixent for Adolescents priority review, Restylane Lyft via cannulas, Hyperhidrosis Awareness
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-dupixent-for-adolescents-priority-review-restylane-lyft-via-cannulas-hyperhidrosis-awareness/18215/FDA grants priority review for Sanofi's and Regeneron's sBLA for Dupixent (dupilumab) for adolescents. Galderma's Restylane Lyft is approved for use with a small, blunt-tip cannula for cheek augmentation and the correction of age-related midface contour deficiencies in patients over the age of 21. TLift Off: Non-Invasive Skin Tightening
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/lift-off-non-invasive-skin-tightening/18223/Arisa Ortiz, MD says that minimally invasive devices won't approach surgical results, but patients can get significant improvement. She discusses patient selection, expectations, and outcomes with host Joel L. Cohen, MD.BrightGuard Covers NYC, Galderma Uncovers Rosacea Burden, Dermira's Qbrexza Approved
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-brightguard-covers-nyc-galderma-uncovers-rosacea-burden-dermira-s-qbrexza-approved/18288/BrightGuard dispensers have now been installed at 53 public pools and 11 beaches in various locations throughout metropolitan New York. The impact of rosacea can be significant for affected patients. According to survey results released last month by Galderma, 86% of patients with rosacea modify theAesthetic A-Peel: Using Peels in Practice
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/aesthetic-a-peel-using-peels-in-practice/18556/As devices continue to evolve so do more "conventional" treatments, like peels. Dr. Gilbert talks about advancements in peels and the rise of nutraceuticals.Open Access: Thoughts for the Ballot Box
https://practicaldermatology.com/topics/practice-management/open-access-thoughts-for-the-ballot-box/20908/Access to drugs, derms at stake in US presidential election.7 Tips to Expand Your Dermatology Social Network
https://practicaldermatology.com/topics/practice-management/7-tips-to-expand-your-dermatology-social-network/20967/Leverage the power of your social media accounts to generate more traffic for your dermatology practice.